The Warnings Page: FDA Warns Purdue Pharma of Misleading Oxycontin Ads and More
February 20, 2003
FDA Issues Stern Warning to Purdue Pharma
Regarding Misleading Oxycontin Advertisements
photo-4WASHINGTON - The FDA issued a stern warning to Purdue Pharma, the company that manufacturers the prescription pain reliever Oxycontin, regarding two advertisements that downplayed the drug's ability to cause fatal side effects and its potential for abuse.
The Jan. 17 Warning Letter states the ads that appeared in the Oct. 2 and Nov. 13 issues of the Journal of the American Medical Association 'grossly understate' the drug's safety because the aforementioned risks, which usually appear in the product's boxed warning, were published in fine print rather than …
UPCOMING CONFERENCES
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach